Dyne Therapeutics, Inc. Public Float
Dyne Therapeutics, Inc. (DYN) had Public Float of $948.00 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $948.00M.
- 2024-06-28: Entity Public Float $3.00B.
- 2023-06-30: Entity Public Float $504.00M.
- 2022-06-30: Entity Public Float $216.30M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $948.00M 10-K · filed 2026-03-02 | |
| 2024-06-28 | $3.00B 10-K · filed 2025-02-27 | |
| 2023-06-30 | $504.00M 10-K · filed 2024-03-05 | |
| 2022-06-30 | $216.30M 10-K · filed 2023-03-02 | |
| 2020-06-30 | $629.30M 10-K · filed 2022-03-10 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |